【レポートの概要（一部）】
1. Report Overview
1.1 The Drug Discovery Outsourcing Market Overview
1.2 Drug Discovery Outsourcing Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
2. An Introduction to Drug Discovery Outsourcing
2.1 What is Outsourcing?
2.2 What is Drug Discovery Outsourcing?
2.3 Why Outsource Drug Discovery?
2.4 A Common Drug Discovery Model Includes Pharmaceutical Organizations Collaborating with Academia
2.5 The Outsource Model for Drug Development Increases Innovation
2.6 Outsourced Processes in Drug Discovery
2.7 Challenges with Drug Discovery Outsourcing
2.8 Emerging Markets are a Popular Destination for CROs
2.9 Strategic Partnerships to Acquisitions
2.10 Recent Drug Development Outsourcing Agreements
2.11 Glossary of Terms Related to Drug Discovery Outsourcing
3. Global Drug Discovery Outsourcing Market and Service Area Submarkets, 2016-2026
3.1 Drug Discovery Outsourcing: Global Market Overview
3.2 The Global Drug Discovery Outsourcing Market Sectors
3.3 The Global Drug Discovery Outsourcing Market by Sector, 2015
3.4 The Global Drug Discovery Outsourcing Market by Sector, 2015-2026
3.5 The Changing Market Shares by Sector, 2015-2026
3.6 The Global Chemistry Services Outsourcing Market, 2015
3.6.1 Libraries
3.6.2 Building Blocks
3.6.3 Compound Synthesis
3.6.4 The Global Chemistry Services Outsourcing Market Forecast, 2015-2026
3.7 The Global Biology Services Outsourcing Market, 2015
3.7.1 Target Identification
3.7.2 Target Validation
3.7.3 The Global Biology Services Outsourcing Market Forecast, 2015-2026
3.8 The Global Lead Optimisation Market, 2015
3.8.1 ADMET Screening: Prevents Late Stage Failure of Clinical Trials
3.8.2 The Global Lead Optimisation Market Forecast, 2015-2026
3.9 The Global Lead Identification and Screening Outsourcing Market, 2015
3.9.1 Methods of Screening in Drug Discovery
3.9.2 Primary Screening
3.9.3 The Global Lead Identification and Screening Outsourcing Market Forecast, 2015-2026
4. The Leading National Markets in the Drug Discovery Outsourcing Market 2015-2026
4.1 Drug Discovery Outsourcing Overview
4.2 The Leading National Markets in the Drug Discovery Outsourcing Market, 2015
4.3 The Leading National Markets in the Drug Discovery Outsourcing Market, 2015-2026
4.4 The Changing Market Shares of the Leading National Markets in the Drug Discovery Outsourcing Market, 2015-2026
4.5 CAGRs of the Leading National Markets in the Drug Discovery Outsourcing Market, 2015-2026
4.6 The US Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.7 The EU5 Drug Discovery Outsourcing Market by Region, 2015
4.7.1 The EU5 Drug Discovery Outsourcing Market Forecast, 2015-2026
4.7.2 CAGRs by EU5 Region, 2015-2026
4.7.3 The EU5 Changing Market Shares by Country 2015-2026
4.7.3.1 The German Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.7.3.2 The UK Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.7.3.3 The French Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.7.3.4 The Italian Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.7.3.5 The Spanish Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.8 The Japanese Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.9 The Chinese Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.9.1 Challenges to China’s Growth
4.10 The Indian Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.11 The Brazilian Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.12 The Russian Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.13 The South Korean Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.14 The Mexican Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.15 The Rest of the World Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
5. Leading Companies in the Drug Discovery Outsourcing Market
5.1 Drug Discovery Outsourcing: A Fragmented and Growing Marketplace
5.2 Characteristics of Leading Contract Research Organisations
5.2.1 A Highly Quality Workforce
5.2.2 Emphasis on Intellectual Property Protection
5.2.3 Long Term Working Relationship
5.2.4 Success in Project Completion
5.2.5 Internal Drug Discovery Programmes
5.3 Service Offerings of Leading Companies in the Drug Discovery Outsourcing Market
5.4 Albany Molecular Research (AMRI)
5.4.1 Historical Sales and Recent Financial Performance, 2011-2014
5.4.2 AMRI’s Drug Discovery Services
5.4.3 Internal Portfolio of Drug Discovery and Development Programme Collaborations
5.4.4 AMRI (DDS) Sales Forecast, 2015-2026
5.5 Aptuit
5.5.1 INDIGO: Accelerating Early Drug Candidates
5.5.2 Aptuit Clinical Trial Supplies
5.5.3 Strategic Partnerships, Acquisitions and Divestitures
5.5.3.1 Divestiture of Aseptic Clinical Manufacturing
5.5.3.2 Aptuit’s Extended Partnership with GSK for VeronaCentre
5.5.3.3 Partnership with Siena Biotech
5.5.3.4 Partnership with Laurus Labs
5.6 Charles River Laboratories
5.6.1 Sales and Historical Financial Performance, 2011-2014
5.6.2 Charles River Laboratories: An External Acquisition Strategy
5.6.2.1 Acquisition of ChanTest
5.6.2.2 Acquisition of Galapagos’ CRO Services Division (BioFocus and Argenta)
5.6.2.3 Acquisition of VivoPath
5.6.3 Charles River Laboratories: Revenue and Financial Analysis, 2014
5.6.3.1 Charles River Laboratories: Historical Financial Performance by Business Segment, 2013-2014
5.6.4 Charles River Laboratories Sales Forecast, 2015-2026
5.7 Covance (Acquired by Laboratory Corporation of America)
5.7.1 Covance: Historical Revenue and Financial Performance, 2010-2013
5.7.2 Covance: Early Stage Discovery Efforts
5.7.3 Agreement with Sanofi
5.7.4 Agreement with Kellogg Company
5.7.5 Agreement with Bio Pontis Alliance
5.7.6 Agreement with Indiana Clinical and Translational Sciences Institute (CTSI)
5.7.7 Agreement with EliLilly
5.8 Cyprotex
5.8.1 Historical Revenue and Financial Performance, 2011-2014
5.8.2 Cyprotex: Revenue by Region, 2015
5.8.3 Cyprotex: Revenue Analysis and Forecast 2015-2026
5.9 Domainex
5.9.1 Drug Pipeline
5.9.2 TBK1/ IKKεInhibitors
5.9.3 Methyltransferase (KMTS) Inhibitors
5.10 Evotec
5.10.1 Strategic Action Plan
5.10.2 Evotec: Historical Revenue and Financial Analysis, 2010-2014
5.10.3 EVT Integrate and EVT Innovate
5.10.4 Partnerships with Pharma for Drug Discovery
5.10.4.1 Partnership with Sanofi
5.10.4.2 Extended Partnership with Evotec
5.10.4.3 Partnership with Johnson & Johnson
5.10.4.4 Partnership with AstraZeneca
5.10.4.5 Partnership with Bayer Pharmaceuticals
5.10.4.6 Partnership with Boehringer Ingelheim Pharma
5.10.4.7 Collaboration with CHDI
5.10.4.8 Collaboration with Janssen
5.10.4.9 Collaboration with MedImmune
5.10.4.10 Collaboration with UCBPharma
5.10.5 Evotec Sales Forecast, 2015-2026
5.11 GenScript
5.11.1 GenScript: Agreements and Partnerships
5.12 Pharmaceutical Product Development (PPD)
5.12.1 PPD: Agreements, Strategic Partnerships and Private Merger
5.12.1.1 Acquisition of Acurian
5.12.1.2 Partnership with Elan
5.12.1.3 Partnership with GSK
5.13 Quintiles
5.13.1 Quintiles: Historical Revenue and Financial Performance, 2009-2014
5.13.2 Development Deal With Merck
5.13.3 Quintiles: Acquisition of Advion Bioanalytical Labs
5.13.4 Quintiles: SheddingJobs
5.13.5 Quintiles Sales Forecast, 2015-2026
5.14 Selcia
5.14.1 A Strong Natural Product Chemistry Track Record
5.14.2 Initiative with the University of Edinburgh
5.14.3 Collaboration with Cantab
5.15 Viva Biotech
5.15.1 GPCR Targeted Discovery Programs
5.15.2 Antibody Therapeutics Discovery
5.16 WIL Research Laboratories
5.16.1 Focus on Preclinical Research
5.16.2 Acquisition of Ricerca Biosciences LLC
5.16.3 Acquisition of Midwest Bio Research
5.17 WuXi Apptec
5.17.1 WuXi AppTec: Service Offerings
5.17.2 Acquisition of Next CODE Health
5.17.3 WuXiAppTec: Historical Revenue and Financial Performance, 2010-2014
5.17.4 WuXiAppTec: Laboratory Services Sales Forecast, 2015-2026
6. Quantitative Analysis of the Drug Discovery Outsourcing Market, 2016-2026
6.1 Drivers and Restraints in the Drug Discovery Outsourcing Market, 2016-2026
6.2 SWOT Analysis of the Drug Discovery Outsourcing Market, 2016-2026
6.3 Strengths
6.3.1 Cost Reduction: A Central Driver for Outsourcing
6.3.2 Accelerating the Discovery of Drug Candidates
6.3.3 Growth of Virtual Pharmaceutical Companies
6.3.4 Reduction in R&D capacity Within Big Pharma
6.4 Weaknesses
6.4.1 Slowing Trajectory of Growth for R&D Spending
6.4.2 Increasingly Saturated Market Requires Companies to Quickly Evolve
6.5 Opportunities
6.5.1 The Available Scope for the Expansion of CROs
6.5.2 Targeted Therapies: Advances in Biologics and Orphan Drugs
6.5.3 Increasing Development of Biologics and Biosimilars
6.6 Threats
6.6.1 A Competitive Market is Increasing Consolidation
6.6.2 Threat of Private Public Alliances
6.6.3 Intellectual Property Leaks
6.6.4 Challenges of Technology Transfer
6.7 Porter’s Five Force Analysis of the Drug Discovery Outsourcing Market
6.7.1 Threat of New Entrants: Medium
6.7.2 Power of Suppliers: Medium
6.7.3 Threat of Substitutes: Medium
6.7.4 Power of Buyers: High
6.7.5 Rivalry Among Competitors: High
7. Expert Opinions
7.1 Interview with Dr. Mario Polywka, Chief Operating Officer, Evotec
7.1.1 Bridging the Gap Between Academia and BigPharma
7.1.2 Evotec: Specialises in Certain Disease Therapies
7.1.3 Complete Drug Discovery Outsourcing: A Growing Trend
7.1.4 Strategies for Drug Discovery Outsourcing Expansion
7.1.5 Building Trust in Collaborations
7.1.6 Evotec: Proven Track Record of Success
7.2 Dr. John Davis, Director of Discovery and Dave Roberts, Business Development Director, Radiochemistry, Selcia
7.2.1 Growth in the Full Spectrum of Outsourcing Services
7.2.2 Natural Products: Increasing Source of Drug Discovery
7.2.3 Strong Pool of Early Drug Candidates
7.2.4 Overcoming Drug Discovery Challenges using Drug Discovery
7.2.5 Selcia: Regional Base of Clients
7.2.6 Drug Discovery and Emerging Technologies
7.2.7 Med Chem Plus Projects
7.2.8 Varied Customer Base
7.2.9 CROs: Improving Drug Discovery Productivity Levels?
7.3 Interview with Dr. Paul Overton, Executive VP, Business Development & Marketing, Aptuit
7.3.1 End-to-End Drug Discovery Integration Growth
7.3.2 Whole Project Externalisation
7.3.3 Drug Discovery Outsourcing: One of Aptuit’s Fastest Growing Services
7.3.4 Aptuit INDiGO® Program
7.3.5 Aptuit Implementation Drug Discovery Acquisitions
7.3.6 Aptuit: Adding the Intellectual Capabilities for Drug Discovery
7.3.7 Several Partners in the Drug Discovery Model
8. Conclusion
8.1 Market Overview
8.2 Lead Optimisation will be the Fastest Growing Sector
8.3 The Drug Discovery Outsourcing Market in Emerging Market Shows Huge Gains
8.4 Continued Growth in Alliances and Collaborations
8.5 Concluding Remarks
【レポート販売概要】
■ タイトル：創薬アウトソーシングの世界市場予測2016-2026■ 英文：Drug Discovery Outsourcing Market Forecast 2016-2026
■ 発行日：2016年9月
■ 調査会社：visiongain
■ 商品コード：VGAIN61119
■ 調査対象地域：グローバル
- コンパニオン診断（CDx）の世界市場Companion Diagnostics (CDx) – your guide to developments, opportunities and revenues See what the future holds for companion diagnostics. Visiongain’s brand new report gives you revenue predictions for the CDx market and its submarkets from 2015, helping you stay ahead. Our 197-page report provides 114 tables, charts, and graphs. Discover the growing trends of this industry. In particular, our new …
- ルーマニアの原子力発電市場2016：発電能力、生産、投資動向、制度、企業Nuclear Power in Romania, Market Outlook to 2030, Update 2016 - Capacity, Generation, Investment Trends, Regulations and Company Profiles Summary "Nuclear Power in Romania, Market Outlook to 2030, Update 2016 - Capacity, Generation, Investment Trends, Regulations and Company Profiles” is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and u …
- 自動車用HVAC市場およびキャビンコンフォート市場The present generation vehicles manufactured are equipped with many features which differ in functions performed, cost and application of the system. These features make the vehicle very comfortable for people to carry out their daily activities. This report deals with five such features - HVAC systems, power windows, power seats, heated seats and sunroofs. The HVAC systems and power windows are c …
- ビデオストリーミングの世界市場：構成要素別（ソリューション＆サービス）、ソリューションタイプ別（IPTV、オーバーザトップ、有料テレビ）、ストリーミングタイプ別（ライブ/リニアビデオストリーミング、ノンリニアビデオストリーミング）、展開モード別（クラウド、オンプレミス、ハイブリッド）、収益モデル別（サブスクリプション、トランザクション、広告、ハイブリッド）、エンドユーザー別（消費者、企業）In video streaming the data from a video file is continuously delivered via the Internet to a remote user. By using video streaming platforms, user can view a video online without being downloaded on a host computer or device. Video streaming technology helps organizations to modernize their daily operations such as live table conferences, scheduling meetings, and interacting internally with custo …
- AltaGas Ltd.：石油・ガスバリューチェーン分析レポート2013AltaGas Ltd. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "AltaGas Ltd." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “AltaGas Ltd.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company’s busin …
- 先進パッケージング・ソリューションの世界市場2015-2019Technavio’s market research analysts predict the global advanced packaging market to grow at a CAGR of close to 8% until 2019. To calculate the market size, analysts have considered revenues generated by global advanced packaging solution providers. The market is segmented according to the technology offered by the major players and on the basis of geography. The global advanced packaging market c …
- 大うつ病性障害：グローバル企業動向PharmaPoint: Major Depressive Disorder - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Major Depressive Disorder - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Major Depressive Disorder Market. The report identifies and analyses the key companies shapi …
- 2014年戦略提言：日本の病院血液及びフローサイトメトリー市場This new report from Venture Planning Group contains 233 pages, 15 tables, and presents a comprehensive analysis of the Japanese hospital hematology and flow cytometry markets, including: Major issues pertaining to the Japanese hematology and flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the nex …
- 消費財（CPG）物流の世界市場2016-2020About the Consumer Packaged Goods (CPG) Logistics Market CPG logistics is a business process that involves the management and movement of consumer packaged goods from the point of origin to the point of consumption. It is a core part of supply chain management (SCM) and includes services such as freight forwarding and multimodal transport through air, ship, truck, and rail. It also provides custom …
- 気腫(Emphysema)：治療薬開発パイプライン動向（2015年上半期版）Emphysema - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Emphysema - Pipeline Review, H1 2015’, provides an overview of the Emphysema’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Emphysema, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of admin …
- 世界のNFC POS端末市場動向（2014-2018）TechNavio's analysts forecast the Global NFC POS Terminals market to grow at a CAGR of 57.9 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing penetration of NFC-based mobile handsets. The Global NFC POS Terminals has also been witnessing the increasing penetration of NFC POS terminals in the Transportation sector for ticketing transactio …
- アジア太平洋のパッケージ変電所市場予測（～2020）The Asia-Pacific package substation market is expected to reach USD 3.04 Billion by 2020, at a CAGR of 7.82% from 2015 to 2020. The growth of this market is attributed to huge electricity demand and modernization of existing power infrastructure in developing countries. Investments for renewable power generation in South Asian countries have been planned to meet the rising power demand, which in t …
- 北米の微細セルポリウレタンフォーム市場The North America microcellular polyurethane foam market is estimated to be at USD 1,211.0 million in 2016 and is projected to reach USD 1,538.0 million by 2021, at a CAGR of 4.9% from 2016 to 2021.Microcellular polyurethane foams are innovative materials that are highly durable and light in weight. They are used in varied industries, such as automotive, aerospace, and construction, owing to their …
- 世界の超臨界圧ボイラー市場2015The Global Supercritical Boilers Industry Report 2015 is a professional and in-depth study on the current state of the Supercritical Boilers industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Supercritical Boilers market analysis is provided for the international markets including development trends, …
- 有効成分の世界市場：製造タイプ別、地域別Global Active Pharmaceutical Ingredients Market: About this market Technavio’s active pharmaceutical ingredients market analysis considers sales from captive API and contract API. Our study also finds the sales of active pharmaceutical ingredients in Asia, Europe, North America, and ROW. In 2019, the contract API segment had a significant market share, and this trend is expected to continue over t …
